Target intelligence / Profile preview

Natural antisense transcript to collagen-like tail subunit of asymmetric acetylcholinesterase (COLQ)

Molecular classification
Long noncoding RNA (lncRNA), natural antisense transcript (NAT), RNA
01

Overview

This molecule is a natural antisense transcript (NAT) located opposite the COLQ gene locus. NATs are a class of noncoding RNAs transcribed from the DNA strand opposite to protein-coding genes. Many NATs regulate the expression of their sense (protein-coding) partners through epigenetic silencing, RNA interference, or by influencing mRNA processing and stability[2][3]. The transcript antisense to COLQ is annotated by genomic analyses but has not been experimentally characterized for function, disease association, or clinical relevance. There are no drugs, known biomarker roles, or safety signals associated with this NAT. Natural antisense transcripts (NATs) are prevalent throughout eukaryotic genomes and modulate gene expression through a variety of mechanisms, including transcriptional interference, RNA masking, recruitment of chromatin-modifying complexes, and, sometimes, the formation of double-stranded RNAs that trigger gene silencing[2][3]. In most cases, including the antisense to COLQ, the specific function remains unknown, though regulatory potential is inferred from the general properties of such transcripts.

Other names
ENSG00000288077novel transcript antisense to COLQCOLQ NATantisense RNA to COLQ
02

Biological functions

Gene expression regulation (by analogy with other NATs)Epigenetic modification (possible, based on known NAT mechanisms)RNA masking or RNA interference (possible mechanism, based on general NAT roles)

Beyond the preview

Go deeper on Natural antisense transcript to collagen-like tail subunit of asymmetric acetylcholinesterase (COLQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural antisense transcript to collagen-like tail subunit of asymmetric acetylcholinesterase (COLQ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call